Research
June 22, 2026
UAMS Receives $2.9 Million to Study Fetal Alcohol Spectrum Disorders
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has received a $2.9 million federal grant to study fetal alcohol spectrum disorders (FASD) and associated neurologic aftereffects, with the goal of discovering new treatments and preventions. This research aims to prevent disability and life-changing conditions that negatively impact our youngest patients. Paul D….
June 16, 2026
UAMS Awarded $2.6 million for Joint M.D./Ph.D. program
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has been awarded a $2.6 million grant from the National Institutes of Health to help train joint M.D./Ph.D. students to become top-notch clinician-scientists.
June 10, 2026
Funding Renewed for UAMS-led Biomedical Research Program, Bringing INBRE’s 30-Year-Total to More Than $107 Million
LITTLE ROCK — A federal grant that funds Arkansas INBRE, a statewide biomedical research program led by the University of Arkansas for Medical Sciences (UAMS), has been extended for another five years, providing 30 years of continuous funding totaling more than $107 million. The latest grant from the National Institute of General Medical Sciences, which…
College Students Gain Understanding of Substance Use Through INBRE Workshop
Thirty college students from across the country recently gathered at the University of Arkansas for Medical Sciences to learn about one of medicine’s most pressing challenges, the opioid crisis.
June 9, 2026
Mitch McGill, Ph.D., Is Part of Research Group Examining Liver Safety Biomarker
Mitch McGill, Ph.D., faculty at the University of Arkansas for Medical Sciences (UAMS), is part of a nationwide collaboration that recently succeeded in obtaining FDA acceptance of a new biomarker, dehydrogenase (GLDH) biomarker. Glutamate dehydrogenase is an enzyme located primarily in the liver. According to the United States Food and Drug Administration (FDA), a biomarker…
May 22, 2026
UAMS Drug Discoveries, Emerging Therapies Highlighted at Research Showcase
Advances at the University of Arkansas for Medical Sciences (UAMS) in developing next-generation treatments for cancer, infectious diseases, retinal injury, and more were the focus of the May 13 Showcase of Medical Discoveries.
May 20, 2026
U of A and UAMS Advance Joint Research Through Razorback Research Catalyst
LITTLE ROCK — Chancellor C. Lowry Barnes, M.D., of the University of Arkansas for Medical Sciences (UAMS) and Chancellor Charles Robinson, Ph.D., of the University of Arkansas, Fayetteville (U of A), announced today the selection of a research team for the inaugural Razorback Research Catalyst, a joint initiative designed to elevate collaborative, high-impact research across both campuses.
May 14, 2026
Conference Highlights Importance of Partnerships in Nursing Research
The University of Arkansas for Medical Sciences (UAMS) hosted a May 1 conference that gave nurses and nursing students from across the state an opportunity to exchange ideas and celebrate the impact of nursing research.
May 13, 2026
UAMS Researchers Identify New Ways to Protect Vision, Regrow Nerves in the Eye
Scientists at the University of Arkansas for Medical Sciences (UAMS) have discovered how to “reprogram” immune cells to help the eye heal after traumatic injuries and diseases such as diabetic retinopathy. Findings from research led by Abdel Fouda, Ph.D., an associate professor in the UAMS College of Medicine’s Department of Pharmacology and Toxicology, were recently…
May 8, 2026
UAMS Highlights Research That Propels New Ideas in Family Medicine
Family medicine researchers from across Arkansas showcased clinical studies and how healthcare is taught and delivered at the University of Arkansas for Medical Sciences (UAMS) Family Medicine Research Symposium.
Next page